SITE009-0081

SITE009 (AUS) › SITE009-0081

SITE009-0081

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2025-12-05

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-05 (study day 212); relationship: NOT RELATED

mild assessed

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-12 (study day 188); relationship: not assessed

mild assessed

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-06-18 (study day 11); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.